Active surveillance of Streptococcus pneumoniae bacteremia in Italian children

Vaccine

Volumn 24, Issue 47-48, 2006, Pages 6938-6943

  Tarallo, L ^a   Tancredi, F ^b   Schito, G ^c   Marchese, A ^c   Bella, A ^d  

^a ASL NA5   (Italy)

^b Centro Direzionale Isola F9   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d NONE   (Italy)

Author keywords

Bacteremia; Children; Italy; Pneumococcal vaccine; Streptococcus pneumoniae

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFACLOR; CEFTAZIDIME; CEFTIBUTEN; CEFTIZOXIME; CEFTRIAXONE; CLARITHROMYCIN; PNEUMOCOCCUS VACCINE; SULTAMICILLIN; VANCOMYCIN;

AGE DISTRIBUTION; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; BLOOD ANALYSIS; BLOOD CULTURE; CONTROLLED STUDY; FEMALE; HEALTH SURVEY; HUMAN; INCIDENCE; INFANT; ITALY; MAJOR CLINICAL STUDY; MALE; NEWBORN; PEDIATRIC HOSPITAL; PRESCHOOL CHILD; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE;

EID: 33846377168     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.05.012     Document Type: Article

References (41)

1. Ho P.L., Lam K.F., Chow F.K., Lau Y.L., Wong S.S., Cheng S.L., et al. Serotype distribution and antimicrobial resistance patterns of nasopharyngeal and invasive Streptococcus pneumoniae isolates in Hong Kong children. Vaccine 22 (2004) 3334-3339
2. Cartwright K. Pneumococcal disease in Western Europe: burden of disease, antibiotic resistance and management. Eur J Pediatr 161 (2002) 188-195
3. Zissis N.P., Syriopoulou V., Kafetzis D., Daikos G.L., Tsilimingaki A., Galanakis E., et al. Serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae causing invasive infections and acute otitis media in children. Eur J Pediatr 163 (2004) 364-368
4. Schrag S.J., McGee L., Whitney C.G., Beall B., Craig A.S., Choate M.E., et al., Active Bacterial Core Surveillance Team. Emergence of Streptococcus pneumoniae with very-high-level resistance to penicillin. Antimicrob Agents Chemother 48 (2004) 3016-3023
5. Gilmour R. EpiReview: invasive pneumococcal disease, NSW, 2002. NSW Public Health Bull 16 (2005) 26-30
6. Marchisio P., Esposito S., Schito G.C., Marchese A., Cavagna R., Principi N., and Hercules Project Collaborative Group. Nasopharyngeal carriage of Streptococcus pneumoniae in healthy children: implications for the use of heptavalent pneumococcal conjugate vaccine. Emerg Infect Dis 8 (2002) 479-484
7. Pantosti A., Boccia D., D'Ambrosio F., Recchia S., Orefici G., and Moro M.L. National Surveillance of Bacterial Meningitis; Earss-Italia Study. Inferring the potential success of pneumococcal vaccination in Italy: serotypes and antibiotic resistance of Streptococcus pneumoniae isolates from invasive diseases. Microb Drug Resist 9 Suppl. 1 (2003) S61-S68
8. Esposito S., Bosis S., Cavagna R., Faelli N., Begliatti E., Marchisio P., et al. Characteristics of Streptococcus pneumoniae and atypical bacterial infections in children 2-5 years of age with community-acquired pneumonia. Clin Infect Dis 35 (2002) 1345-1352
9. D'Ancona F., Salmaso S., Barale A., Boccia D., Lo Palco P.L., Rizzo C., et al. Incidence of vaccine preventable pneumococcal invasive infections and blood culture practices in Italy. Vaccine 23 (2005) 2494-2500
10. Andresen D.N., and Collignon P.J. Invasive pneumococcal disease in the Australian Capital Territory and Queanbeyan region: do high infant rates reflect more disease or better detection?. J Paediatr Child Health 40 (2004) 184-188
11. Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH. Manual of Clinical Microbiology. 8th ed., Washington DC, USA, 2003.
12. Marchese A., Tonoli E., Balistreri G., Debbia E.A., and Schito G.C. Antibiotic susceptibility patterns and serotypes of antibiotic resistant and/or invasive Streptococcus pneumoniae strains circulating in Italy. Microbial Drugs Resistance 6 (2000) 163-170
13. National Committee for Clinical Laboratory Standards. (2004). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. Sixth Edition; Approved Standard M7-A6 and M100-S14. Wayne, PA, USA.
14. Shah S.S., Alpern E.R., Zwerling L., McGowan K.L., and Bell L.M. Risk of bacteremia in young children with pneumonia treated as outpatients. Arch Pediatr Adolesc Med 157 (2003) 389-392
15. Alpern E.R., Alessandrini E.A., McGowan K.L., Bell L.M., and Shaw K.N. Serotype prevalence of occult pneumococcal bacteremia. Pediatrics 108 (2001) E23
16. Ispahani P., Slack R.C., Donald F.E., Weston V.C., and Rutter N. Twenty year surveillance of invasive pneumococcal disease in Nottingham: serogroups responsible and implications for immunisation. Arch Dis Child 89 (2004) 757-762
17. Roche P., Krause V., Andrews R., Carter L., Coleman D., Cook H., et al. Pneumococcal Working party of the Communicable Diseases Network Australia. Invasive pneumococcal disease in Australia, 2002. Commun Dis Intell 27 (2003) 466-477
18. Jamuna R., Srinivasan S., and Harish B.N. Factors predicting occult bacteremia in young children. Indian J Pediatr 67 (2000) 709-711
19. Stoll M.L., and Rubin L.G. Incidence of occult bacteremia among highly febrile young children in the era of the pneumococcal conjugate vaccine: a study from a Children's Hospital Emergency Department and Urgent Care Center. Arch Pediatr Adolesc Med 158 (2004) 671-675
20. Alpern E.R., Alessandrini E.A., Bell L.M., Shaw K.N., and McGowan K.L. Occult bacteremia from a pediatric emergency department: current prevalence, time to detection, and outcome. Pediatrics 106 (2000) 505-511
21. Pineda V., Fontanals D., Larramona H., Domingo M., Anton J., and Segura F. Epidemiology of invasive Streptococcus pneumoniae infections in children in an area of Barcelona, Spain. Acta Paediatr 91 (2002) 1251-1256
22. Rodriguez-Creixems M., Berto J., Munoz P., Alonso R., Alcala L., and Bouza E. Increased incidence of pneumococcal bloodstream infections. Pediatr Infect Dis J 22 (2003) 661-663
23. Dominguez A., Salleras L., Cardenosa N., Ciruela P., Carmona G., Martinez A., et al. The epidemiology of invasive Streptococcus pneumoniae disease in Catalonia (Spain): a hospital-based study. Vaccine 20 (2002) 2989-2994
24. Kaltoft, Zeuthen N., and Konradsen H.B. Epidemiology of invasive pneumococcal infections in children aged 0-6 years in Denmark: a 19-year nationwide surveillance study. Acta Paediatr 89 Suppl (2000) 3-10
25. Syriopoulou V., Daikos G.L., Soulis K., Michos A., Alexandrou H., Pavlopoulou I., et al. Epidemiology of invasive childhood pneumococcal infections in Greece. Acta Paediatr 89 Suppl. (2000) 30-34
26. Ulloa-Gutierrez R., Avila-Aguero M.L., Herrera M.L., Herrera J.F., and Arguedas A. Invasive pneumococcal disease in Costa Rican children: a seven year survey. Pediatr Infect Dis J 22 (2003) 1069-1074
27. Kaplan S.L., Mason Jr. E.O., Wald E., Tan T.Q., Schutze G.E., Bradley J.S., et al. Six years multicenter monitoring of invasive pneumococcal infections in children. Pediatr Infect Dis J 21 (2002) 141-147
28. Perez Lopez A., Gimenez M., Rodrigo C., Alonso A., Prat C., and Ausina V. Seven-year review of paediatric bacteraemias diagnosed in a Spanish university hospital. Acta Paediatr 92 (2003) 854-856
29. Canet J.J., Juan N., Xercavins M., Freixas N., Garau J., et al. Hospital-acquired pneumococcal bacteremia. CID 35 (2002) 697-702
30. Kaplan S.L., Mason Jr. E.O., Barson W.J., Wald E.R., Arditi M., Tan T.Q., et al. Three-year multicenter surveillance of systemic pneumococcal infections in children. Pediatrics 102 (1998) 538-545
31. Spanjaard L., van der Ende A., Rumke H., Dankert J., and van Alphen L. Epidemiology of meningitis and bacteraemia due to Streptococcus pneumoniae in The Netherlands. Acta Paediatr 89 Suppl (2000) 22-26
32. Totapally B.R., and Walsh W.T. Pneumococcal bacteremia in childhood: a 6-year experience in a community hospital. Chest 113 (1998) 1207-1214
33. Flamaing J., Verhaegen J., and Peetermans W.E. Streptococcus pneumoniae bacteraemia in Belgium: differential characteristics in children and the elderly population and implications for vaccine use. J Antimicrob Chemother 50 (2002) 43-50
34. Rothermel C.D. Penicillin and macrolide resistance in pneumococcal pneumonia: does in vitro resistance affect clinical outcomes?. Clin Infect Dis 38 Suppl 4 (2004) S346-S349
35. Silverstein M., Bachur R., and Harper M.B. Clinical implications of penicillin and ceftriaxone resistance among children with pneumococcal bacteremia. Pediatr Infect Dis J 18 (1999) 35-41
36. Marchese A, Ardito F, Fadda G, Gualco L, Mezzatesta M, Nicoletti G, et al. Protekt Italia - Analisi dei risultati del primo anno di studio (2002). GIMMOC 2004;VIII(4 Dicembre 2004):195-224.
37. Marchese A, Ardito F, Fadda G, Gualco L, Mezzatesta M, Nicoletti G, et al. Protekt Italia - Analisi dei risultati del secondo anno di studio (2003). GIMMOC 2004;VIII(4 Dicembre 2004):225-56.
38. Lagos R., Munoz A., Valenzuela M.T., Heitmann I., and Levine M.M. Population-based surveillance for hospitalized and ambulatory pediatric invasive pneumococcal disease in Santiago, Chile. Pediatr Infect Dis J 21 (2002) 1115-1123
39. Dagan R. Antibiotic resistance and the potential impact of pneumococcal conjugate vaccines. Commun Dis Intell 27 Suppl (2003) 34-42
40. Ruhe J.J., and Hasbun R. Streptococcus pneumoniae bacteremia: duration of previous antibiotic use and association with penicillin resistance. Clin Infect Dis 36 (2003) 1132-1138
41. Piano Nazionale vaccini 2005-2007. Gazzetta Ufficiale Repubblica Italiana 2005;86: Suppl. 63.